Document Detail


Hematopoietic modulators as potential agents for the treatment of leukemia.
MedLine Citation:
PMID:  23276976     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Leukemias are the most common malignancy of childhood and have the highest mortality among aging people. Leukemias are a group of blood disorders characterized by an accumulation of leukemic cells in the peripheral blood of patients as a result of disturbances in proliferation and differentiation. Refractory leukemia remains the most common therapeutic challenge. In recent years, the presence of a cancer stem cell population in leukemias has been proposed as a cause for the refractory phenomenon. Insights into the cellular and molecular features of leukemia led to a new point of view in the choice of novel therapeutic agents. New agents for the treatment of this disease should selectively target leukemia stem cells or exhibit higher cytotoxic effects in cancer cells than in normal cells. A special interest is focused on anticancer agents from biological and natural sources that can be used in the treatment of leukemia. This review discusses the characteristics of some of these potential new agents.
Authors:
Edgar J Paredes-Gamero; Amanda Nogueira-Pedro; Antonio Miranda; Giselle Zenker Justo
Related Documents :
24344806 - The neurotrophic hepatocyte growth factor attenuates cd8+ cytotoxic t-lymphocyte activity.
24633226 - Costimulation via the tumor-necrosis factor receptor superfamily couples tcr signal str...
23795946 - Myc status determination in aggressive b-cell lymphoma: the impact of fish probe select...
22967076 - Role of mass spectrometry-based proteomics in the study of cellular reprogramming and i...
8812686 - Natural killer cell subsets and development
3489436 - Classification and differential diagnosis of 20 problem cases of occidental malignant t...
Publication Detail:
Type:  Journal Article     Date:  2013-01-01
Journal Detail:
Title:  Frontiers in bioscience (Elite edition)     Volume:  5     ISSN:  1945-0508     ISO Abbreviation:  Front Biosci (Elite Ed)     Publication Date:  2013  
Date Detail:
Created Date:  2013-01-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101485240     Medline TA:  Front Biosci (Elite Ed)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  130-40     Citation Subset:  IM    
Affiliation:
Universidade Federal de Sao Paulo, Departamento de Biofisica, Rua Botucatu,862, 2 Andar, CEP, 04023-062, Sao Paulo, SP, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vascular endothelial cells and dysfunctions: role of melatonin.
Next Document:  PET/CT in the imaging of ovarian Cancer.